This entity, termed lobular-like invasive mammary carcinomas (LLIMCas), is characterized by E-cadherin and p120 immunopositivity and an absence of CDH1 loss-of-function mutations, which are common in classic ILCs [3]. This evidence concerns the gene CDH1 and invasive breast carcinoma.